NAPIGEN, INC.
PrivateLast Round
Grant
Mar 11, 2024
Total Funding Raised
$9.65M
Company Overview
NAPIGEN, INC. is a biotechnology and AgTech company that provides novel genome engineering of organisms such as plants, microbes, and animals by targeting cellular components known as mitochondria and chloroplasts.
Sector
Frontier & Industrial Tech
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NAPIGEN, INC. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NAPIGEN, INC. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 11, 2024 | ||||
| Series A | Mar 11, 2024 | ||||
| Seed | Jul 12, 2022 | ||||
| Grant | May 14, 2020 | ||||
| Grant | Jan 1, 2020 | ||||
Grant | Dec 12, 2019 |
NAPIGEN, INC. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SVG Ventures|THRIVE | Seed, Accelerator |
| RA Capital Management | Seed |
| Thiel Foundation | Seed |
| NIH RADx | Grant |
| United Mitochondrial Disease Foundation | Seed, Grant |
| The Grantham Foundation for the Protection of the Environment | Seed |
| Delaware Division of Small Business | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2024
$175K grant from the U.S. Department of Agriculture.
- Jul 12, 2022
$7.85M round led by RA Capital Management.
NAPIGEN, INC. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NAPIGEN, INC.'s valuation, stock price, and market status.